Particle Therapy Market is expected to increase at a compound annual growth rate (CAGR) of 9.6% from 2025 to 2035
The particle therapy
market was estimated to be worth USD 2.5 billion in 2024 and is
expected to grow at a compound annual growth rate (CAGR) of 9.6% from 2025 to
2035, reaching USD 3.6 billion. Particle treatment enhances disease control and
lessens damage to healthy tissue. The market is sustainable and expanding since
it is in line with the healthcare industry.
Particle
therapy is a form of external beam radiation used to treat malignant tumors,
mostly with proton beams. Hadron treatment is another, more technical term for
particle therapy. The majority of particle beam radiation used in this therapy
is precisely administered and has special physical properties that reduce
collateral damage to healthy tissues.
Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/particle-therapy-market
GROWTH
DRIVERS
The main factor
propelling the market's expansion is the increase in cancer incidence
worldwide. According to the 2022 report by the International Agency for
Research on Cancer (IARC), lung and breast cancer are the most common cancers,
accounting for 20 million new cases and 9.7 million deaths worldwide. The need
for better healthcare infrastructure and access to affordable cancer services
is further highlighted by the projection that the number of cancer cases will
rise to 35 million by 2050, especially in low and medium HDI nations.
Innovations and
technological breakthroughs combined with affordability drive market uptake and
expansion. Adoption of the market is greatly boosted by the rise in spending in
research and clinical studies meant to strengthen the efficacy of particle therapy
for different forms of cancer. The University of Wisconsin-Madison, for
example, started projects in May 2024 that focused on particle beam radiation,
such as proton therapy, in which radiation travels to a certain depth in the
tissue and then stops, minimizing the amount of potentially hazardous radiation
that reaches healthy tissues and protecting patients from certain
treatment-related toxicities.
MARKET
SEGMENTATION:
· By
Therapy Type- proton therapy (cyclotron and synchrotrons), heavy-ion
therapy and hybrid particle therapy
· By
Room Configuration Type- single room and multi room
· By
Application- research and treatment
· By
Cancer Type- pediatric cancer, breast cancer, lung cancer, prostate cancer,
colorectal cancer, liver cancer and others
· By
Region- North America, Europe, Asia Pacific, Middle & Africa and
South America
Global
Key Players:
· IBA
Worldwide
· Varian
Medical Systems
· Hitachi
· Mevion
Medical Systems
· Optivus
Proton Therapy
· Sumitomo
Heavy Industries, Ltd.
· Danfysik
A/S
· Provision
Healthcare
· Other
Players
For More Information about this Report @
https://www.xresearch.biz/shop/particle-therapy-market
About Us: -
xResearch
is a market research and consulting organization that uses unique data, expert
analysis, and new technologies to create trusted intelligence on industries.
Our research is focused on delivering an informed and impartial view on
essential market data of industry, and it is primarily driven by an in-depth
study covering the following parameters: Market Sizing and Forecasting, Market
Segmentation, Competitive Analysis, Strategic Assessment and Business
Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-619-8140
Websites: https://www.xresearch.biz/

Comments
Post a Comment